Effectiveness and Dosage of Lactobacillus rhamnosus GG for Diarrhea
This conversation explores whether Lactobacillus rhamnosus GG (LGG) can shorten diarrhea duration, citing two studies from Pillser's database. It covers evidence for acute infectious and antibiotic-associated diarrhea, a recommended dose range of 1–10 billion CFU per day, and practical usage notes.
Does taking Lactobacillus rhamnosus GG really help shorten diarrhea, and what dose works best?
Based on Pillser's research database, the evidence supports that Lactobacillus rhamnosus GG (LGG) does help shorten or improve diarrhea across several contexts. Here's what the data shows:
Evidence Summary
Pillser's database contains 2 studies on LGG and diarrhea, with both showing beneficial effects and none showing neutral or harmful results1.
Key Findings
-
Systematic Review (2019): A comprehensive review covering 30 years of LGG research analyzed its effectiveness in gastrointestinal infections, antibiotic-associated diarrhea, and Clostridium difficile-associated diarrhea, confirming clinical benefits2.
-
RCT in Infants (2020): A randomized, double-blind, placebo-controlled trial in infants with cow's milk protein allergy found that those receiving LGG showed statistically significant improvement in diarrhea symptoms (p ≤ 0.001)3.
What Dose Was Used?
The interventional study used 1×10⁹ CFU (colony-forming units) per day3. This is equivalent to 1 billion CFU/day, which is a commonly studied dose for LGG in clinical contexts. However, many clinical trials on LGG for acute diarrhea in children have used doses ranging from 10⁹ to 10¹⁰ CFU/day (1 to 10 billion CFU), typically given for 5–7 days.
Practical Takeaways
- LGG is most well-studied for acute infectious diarrhea (e.g., rotavirus in children) and antibiotic-associated diarrhea.
- Starting early in the course of diarrhea appears to yield the best results.
- A dose around 1–10 billion CFU per day is commonly supported by the evidence.
Note: If you're considering LGG for a specific condition, it's best to consult a healthcare provider, especially for infants, immunocompromised individuals, or those with underlying health conditions.
Footnotes
-
Pillser research database, Lactobacillus rhamnosus GG and Reduced Diarrhea. ↩
-
"Thirty Years of Lactobacillus rhamnosus GG: A Review" (2019), Pillser research database, link. ↩
-
"Investigation of the Efficacy of Lactobacillus rhamnosus GG in Infants With Cow's Milk Protein Allergy" (2020), Pillser research database, link. ↩ ↩2
-